# Potassium Phosphates

NDC: 0517-2505
Generic name: Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic
Labeler / Manufacturer: American Regent, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20231013

FDA application: ANDA216274

## Active ingredients

- POTASSIUM PHOSPHATE, DIBASIC: 236 mg/mL
- POTASSIUM PHOSPHATE, MONOBASIC: 224 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0517-2505"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0517-2505
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41a85cca-c463-4f39-9335-177b04c290a9